Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Plasma zap during brain surgery may keep blood clots from coming back

NCT ID NCT07656818

First seen Jun 20, 2026 · Last updated Jun 20, 2026

Summary

This study tests whether applying a cold plasma (non-thermal plasma) to the surgical site during standard drainage of a chronic subdural hematoma can lower the chance of the blood clot returning within 6 months. Forty adults needing surgery for this condition will be randomly assigned to get standard surgery alone or surgery plus the plasma treatment. The main goal is to see if the plasma reduces recurrence rates and is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Plasma Physics Laboratory, National Institute of Nuclear Research

    RECRUITING

    Ocoyoacac, State of Mexico, 52750, Mexico

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

non-thermal plasma (helium gas)

What this could lead to

If it works, this could offer a simple way to lower the chance of a chronic subdural hematoma coming back after surgery, reducing the need for repeat operations.

What could go wrong

This is a small early-stage trial with only 40 people, so results may not apply widely. The plasma device is new for this use, and its safety and effectiveness are not yet proven.

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural Hematoma, Subdural, Chronic Postoperative Complications Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.